Investment Banking

Eason Hahm Quoted in Reuters

William Blair biotech investment banking director Eason Hahm was quoted in a Reuters story centered on biotech M&A activity in 2026.

“Over $300 billion of revenue in the sector faces LOEs in the next five years,” Hahm told the publication.

Our Latest News

Tuesday, June 9, 2026

FDH Aero Has Agreed to be Acquired by Bain Capital

William Blair acted as financial advisor to FDH Aero, a portfolio company of Audax Private Equity, in connection with its pending sale to Bain Capital.
Read more
Tuesday, June 2, 2026

Sentinel Dock & Door Solutions Has Been Acquired by ASSA ABLOY

William Blair acted as the exclusive financial advisor to Sentinel Dock & Door Solutions, a portfolio company of Trivest Partners, in connection with its sale to ASSA ABLOY.
Read more
Tuesday, June 2, 2026

William Blair Advises Capital A on Raising a Single-Asset Continuation Vehicle for DJZ

William Blair served as the exclusive financial advisor to Capital A Investment Partners (Capital A) on both the raising of its single-asset continuation fund and the concurrent refinancing process of De Jong Zuurmond (DJZ).
Read more

See more news

Are you sure you want to leave?

Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.

For disclosure information, please visit www.williamblair.com/disclosures